| abstract |
A combination comprising a therapeutically effective amount of an aldosterone receptor epoxy-steroidal antagonist and a therapeutically effective amount of an angiotensin converting enzyme inhibitor, wherein said angiotensin converting enzyme inhibitor is selected from the group consisting of alacepril, benazepril. , captopril, cilazapril, delapril, enalapril, enalaprilat, fosinopril, fosinoprilat, imidapril, lisinopril, perindorpil, quinapril, ramipril, saralasin acetate, temocapril, trandolapril, ceranapril, moexipril, chinaprila, birapr37, chirapr37, chinaprila, chirapr37, chinaprila, chirapr37, chinaprila, chirapr37, chinaprila, birapr37, chinaprila, birapr37, chiraprila, birapr37, chinaprila, birapr37, chinaprila, birapr37, chinaprila, birapr37, chinaprila, birapr37 Fisons FPL-66564, idrapril, Marion Merrell Dow MDL-100240, perindoprilat, and Servier S-5590. |